Old Web
English
Sign In
Acemap
>
Paper
>
Denosumab's dynamic CTX profile is maintained over 6 years of treatment: first 3 years of the FREEDOM extension study
Denosumab's dynamic CTX profile is maintained over 6 years of treatment: first 3 years of the FREEDOM extension study
2013
Christian Roux
McClung
Nathalie Franchimont
Silvano Adami
Peter R. Ebeling
Ian R. Reid
H. Resch
Georges Weryha
N. Daizadeh
Andrea Wang
Rachel B. Wagman
Richard Eastell
Keywords:
Physical therapy
Denosumab
Medicine
Forensic engineering
extension study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]